[Federal Register Volume 84, Number 97 (Monday, May 20, 2019)]
[Notices]
[Pages 22849-22850]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10452]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is 
announcing a Special Emphasis Panel (SEP) meeting on AHRQ-HS-19-001, 
``Patient Safety Learning Laboratories (2019): Pursuing Safety in 
Diagnosis and Treatment at the Intersection of Design, Systems 
Engineering, and Health Services Research (R18).''

DATES: June 12, 2019 (Open on June 12th from 8:00 a.m. to 8:15 a.m. and 
closed for the remainder of the meeting).

ADDRESSES: Bethesda Marriott Hotel, 5151 Pooks Hill Rd., Bethesda, MD 
20852.

FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of 
members, agenda or minutes of the non-confidential portions of this 
meeting should contact: Heather Phelps, Acting Committee Management 
Officer, Office of Extramural Research, Education and Priority 
Populations, AHRQ, 5600 Fishers Lane, Rockville, Maryland 20850, 
Telephone: (301) 427-1128.
    Agenda items for this meeting are subject to change as priorities 
dictate.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
AHRQ, and agree to be available, to conduct on an as needed basis, 
scientific reviews of applications for AHRQ support. Individual members 
of the SEP do not attend regularly-scheduled meetings and do not serve 
for fixed terms or a long period of time. Rather, they are asked to 
participate in particular review meetings which require their type of 
expertise.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (5 U.S.C. App. 2), announcement is made of an AHRQ SEP 
meeting on AHRQ-HS-19-001, ``Patient Safety Learning Laboratories 
(2019): Pursuing Safety in Diagnosis and Treatment at the Intersection 
of Design, Systems

[[Page 22850]]

Engineering, and Health Services Research (R18).''
    Each SEP meeting will commence in open session before closing to 
the public for the duration of the meeting. The SEP meeting referenced 
above will be closed to the public in accordance with the provisions 
set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 
U.S.C. 552b(c)(6). Grant applications for the AHRQ-HS-19-001, ``Patient 
Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and 
Treatment at the Intersection of Design, Systems Engineering, and 
Health Services Research (R18)'' are to be reviewed and discussed at 
this meeting. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

Gopal Khanna,
Director.
[FR Doc. 2019-10452 Filed 5-17-19; 8:45 am]
BILLING CODE 4160-90-P